Cargando…

Narsoplimab for severe transplant-associated thrombotic microangiopathy

BACKGROUND: Transplantation-associated thrombotic microangiopathy (TA-TMA) is an endothelial injury syndrome linked to the overactivation of complement pathways. It manifests with microangiopathic hemolytic anemia, consumptive thrombocytopenia, and microvascular thrombosis leading to ischemic tissue...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pandrowala, Ambreen, Ganatra, Parth, Krishnan, V. P., Sharma, Ajay Narayan, Chavan, Saroj, Bodhanwala, Minnie, Agarwal, Bharat, Hiwarkar, Prashant
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009829/ https://www.ncbi.nlm.nih.gov/pubmed/36915123 http://dx.doi.org/10.1186/s12959-023-00464-9

Ejemplares similares

Reduced toxicity conditioning and a high CD34(+) cell dose can achieve full donor chimerism in DOCK8 deficiency
por: Pandrowala, Ambreen, et al.
Publicado: (2023)

Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab
por: Rambaldi, Alessandro, et al.
Publicado: (2020)

Changing outcomes of stem cell transplantation in primary immunodeficiencies: Results from a tertiary-care charitable trust hospital in Mumbai
por: Pandrowala, Ambreen, et al.
Publicado: (2023)

Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation–Associated Thrombotic Microangiopathy
por: Khaled, Samer K., et al.
Publicado: (2022)

MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti‐MASP2 antibody narsoplimab
por: Elhadad, S., et al.
Publicado: (2020)

COVID-19 and thrombotic microangiopathies
por: Tiwari, Nishant R., et al.
Publicado: (2021)

Thrombotic Microangiopathies
por: Radhi, Mohamed, et al.
Publicado: (2012)

The thrombotic microangiopathies
por: Copelovitch, Lawrence, et al.
Publicado: (2008)

Thrombotic Microangiopathy in Haematopoietic Cell Transplantation: an Update
por: Stavrou, Evi, et al.
Publicado: (2010)

Characteristics and management of thrombotic microangiopathy in kidney transplantation
por: Cho, Wonyong, et al.
Publicado: (2023)

Thrombotic microangiopathy after renal transplantation: Current insights in de novo and recurrent disease
por: Abbas, Fedaey, et al.
Publicado: (2018)

Thrombotic microangiopathy in children
por: Palma, Lilian Monteiro P., et al.
Publicado: (2022)

Thrombotic microangiopathy following haematopoietic stem cell transplant
por: Seaby, Eleanor G., et al.
Publicado: (2017)

Cerebral vascular injury in transplant-associated thrombotic microangiopathy
por: Sabulski, Anthony, et al.
Publicado: (2022)

Drug-Induced Thrombotic Microangiopathy Resulting in ESRD
por: Agarwal, Krishna A., et al.
Publicado: (2020)

Thrombotic Microangiopathy in a Patient With COVID-19 Infection and Metastatic Cholangiocarcinoma
por: Sharma, Shruti, et al.
Publicado: (2021)

An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy
por: Aigner, Christof, et al.
Publicado: (2019)

Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
por: Grall, Maximilien, et al.
Publicado: (2021)

Post transplant thrombotic microangiopathy causing acute renal failure
por: Qutube, S., et al.
Publicado: (2009)

Doxycycline for haematopoietic stem cell transplantation-related thrombotic microangiopathy
por: Izzedine, Hassane, et al.
Publicado: (2010)

Thrombotic Microangiopathy in a Kidney Transplant Patient With COVID-19
por: Bascuñana, Arturo, et al.
Publicado: (2020)

Thrombotic Microangiopathy Associated with Pazopanib in a Kidney Transplant Recipient
por: Kalla, Shabana, et al.
Publicado: (2021)

Use of Eculizumab in Pediatric Patients With Transplant Associated Thrombotic Microangiopathy
por: Gomez-Ganda, Laura, et al.
Publicado: (2021)

Thrombotic microangiopathy in juvenile dermatomyositis
por: Frolenko, A, et al.
Publicado: (2011)

Thrombotic microangiopathy in renal allografts
por: Radha, S., et al.
Publicado: (2014)

Influenza-associated thrombotic microangiopathies
por: Bitzan, Martin, et al.
Publicado: (2017)

Acyclovir-induced thrombotic microangiopathy
por: Goli, R., et al.
Publicado: (2017)

Cancer-associated thrombotic microangiopathy
por: Govind Babu, K, et al.
Publicado: (2016)

Complement in Secondary Thrombotic Microangiopathy
por: Palma, Lilian Monteiro Pereira, et al.
Publicado: (2020)

Thrombotic Microangiopathy Syndrome in the ICU
por: Samy Modeliar, S., et al.
Publicado: (2006)

Thrombotic Microangiopathy Syndrome in the ICU
por: Samy Modeliar, S., et al.
Publicado: (2006)

Thrombotic microangiopathy triggered by podocytopathy
por: Veríssimo, Rita, et al.
Publicado: (2021)

Thrombotic microangiopathies: An illustrated review
por: Abou‐Ismail, Mouhamed Yazan, et al.
Publicado: (2022)

Diagnosis and treatment of thrombotic microangiopathy
por: Thompson, Gemma L., et al.
Publicado: (2022)

Chemotherapy-Associated Thrombotic Microangiopathy
por: Aklilu, Abinet M., et al.
Publicado: (2023)

Thrombotic microangiopathy with severe renal failure in adenocarcinoma
por: Lakshminarayana, G., et al.
Publicado: (2008)

von Willebrand Factor as a Predictor for Transplant-Associated Thrombotic Microangiopathy
por: Xu, Zhenzhen, et al.
Publicado: (2020)

Thrombotic Microangiopathy After Kidney Transplantation: An Underdiagnosed and Potentially Reversible Entity
por: Ávila, Ana, et al.
Publicado: (2021)

Antiphospholipid Syndrome Nephropathy with Acute Thrombotic Microangiopathy after Renal Transplantation
por: Suenaga, Atsuhiko, et al.
Publicado: (2023)

Thrombotic microangiopathy and associated renal disorders*
por: Barbour, Thomas, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1g230970nd34vn0pcilhhot31v